Nicholas Company, Inc. Pfizer Inc Transaction History

Nicholas Company, Inc.

$5.92 Billion
Q1 2024

A detailed history of Nicholas Company, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Nicholas Company, Inc. holds 240,960 shares of PFE stock, worth $6.76 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

240,960

Previous 224,525 7.32%

Holding current value

$6.76 Million

Previous $6.46 Million 3.43%

% of portfolio

0.11%

Previous 0.12%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $425,502 - $488,612	16,435 Added 7.32%	240,960 $6.69 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $5.87 Million - $7.62 Million	224,525 New	224,525 $6.46 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $30.1 Million - $38.3 Million	-900,565 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $306,705 - $359,835	-9,660 Reduced 1.06%	900,565 $33.1 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $82,982 - $118,563	3,070 Added 0.34%	910,225 $29.7 Million

Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $5,761 - $6,538	175 Added 0.02%	907,155 $35.5 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $814,686 - $1.06 Million	25,075 Added 2.84%	906,980 $32.6 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $968,321 - $1.09 Million	26,185 Added 3.06%	881,905 $38.2 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $475,125 - $522,004	-12,670 Reduced 1.46%	855,720 $36.3 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $14.7 Million - $16.8 Million	-382,105 Reduced 30.56%	868,390 $37.9 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $1.14 Million - $1.38 Million	-33,000 Reduced 2.57%	1,250,495 $55.1 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $2.74 Million - $2.92 Million	-83,120 Reduced 6.08%	1,283,495 $46.6 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $4.47 Million - $5.19 Million	-140,090 Reduced 9.3%	1,366,615 $48.5 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $311,313 - $330,314	-9,360 Reduced 0.62%	1,506,705 $54.6 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $108,500 - $119,525	-3,500 Reduced 0.23%	1,516,065 $54.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,519,565	1,519,565 $51 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Account

Nicholas Company, Inc. Pfizer Inc Transaction History